Setting Benchmarks for Microsurgical Clipping of Unruptured Intracranial Aneurysms
1 other identifier
observational
3,000
1 country
1
Brief Summary
To conduct a retrospective multicenter cohort study to define benchmark values for best achievable outcomes following microsurgical clipping of unruptured intracranial aneurysms (UIA).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2016
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2020
CompletedFirst Submitted
Initial submission to the registry
August 29, 2021
CompletedFirst Posted
Study publicly available on registry
September 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2022
CompletedSeptember 22, 2022
September 1, 2022
5 years
August 29, 2021
September 21, 2022
Conditions
Outcome Measures
Primary Outcomes (3)
Complete occlusion of aneurysm
Aneurysm remnant in CT scan or angiography
up to 6 months
Retreatment of aneurysm
Necessity of retreatment in endovascular or microsurgical technique
up to 6 months
Mortality
Death of the patient
up to 6 months
Secondary Outcomes (7)
Chronic subdural hematoma
up to 6 months
Stroke
up to 6 months
Cerebral vasospasm
up to 6 months
Intracerebal haemorrhage
up to 6 months
New neurological deficit
up to 6 months
- +2 more secondary outcomes
Interventions
Microsurgical Clipping of Unruptured Intracranial Aneurysm
Eligibility Criteria
Patients who went through elective microsurgical clipping of unruptured intracranial aneurysm
You may qualify if:
- Patients who went through elective microsurgical clipping of unruptured intracranial aneurysm
- High-volume centers with ≥40 cases per year during the study period
You may not qualify if:
- Treatment following subarachnoid haemorrhage
- Clipping following an incomplete occlusion after previous treatment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Medical Center Hamburg-Eppendorf
Hamburg, 20246, Germany
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lasse Dührsen, MD
Universitätsklinikum Hamburg-Eppendorf
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
August 29, 2021
First Posted
September 1, 2021
Study Start
January 1, 2016
Primary Completion
December 31, 2020
Study Completion
December 31, 2022
Last Updated
September 22, 2022
Record last verified: 2022-09